Innovation for Your Health

All news from Hamburg
and Schleswig-Holstein


Eppendorf with new CEO dual leadership

The Supervisory Board of Eppendorf AG has appointed Eva von Pelt, currently Chief Commercial Officer, and Dr. Peter Fruhstorfer, currently Head of Business Area Sample Handling, as Co-Chief Executive...


Evotec expands strategic partnership with Celmatix in women's health

Evotec SE announced an expansion of the Company’s strategic partnership with Celmatix Inc., the leading precision health company advancing the fields of reproductive medicine and fertility at the...


Life Science Nord takes stock of a positive BIO-Europe in Hamburg

The North German cluster management Life Science Nord is more than happy with the results of the international Biotech pharmaceuticals conference that took place from 11 to 13 November at the Hamburg...


Evotec SE: Results and corporate updates

Evotec SE reported financial results and corporate updates for the first nine months ended 30 September 2019....


BIO-Europe: The countdown has begun

Preparations for Europe’s leading conference for the biotech and pharmaceutical industry are entering the crucial stage: Next week, from November 11-13, BIO-Europe will be opening its doors for the...


Evotec and Vifor Pharma form joint venture for early development in nephrology

Evotec SE and Vifor Pharma announced the launch of a 50:50 joint venture focused on the discovery and development of novel nephrology therapeutics. Vifor Pharma will be benefiting from access to an...


Evotec and Celmatix enter into strategic collaboration

Evotec SE and Celmatix Inc., a precision medicine company with a proprietary multi-omics platform, announced a partnership to develop pre-clinical programmes in prevalent but underserved conditions...


Evotec reaches milestone in integrated drug discovery and development partnership with Aeovian

Evotec SE announced that the Company has reached a milestone in a drug discovery and development partnership with the biopharmaceutical company Aeovian Pharmaceuticals, Inc. (“Aeovian”)....


Evotec and Indivumed achieve milestone in joint strategic drug discovery collaboration

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) and Indivumed GmbH announced that the first milestone has been successfully achieved in their joint collaboration to identify...

© Copyright Life Science Nord e.V.

All rights reserved. Especially reprint, incorporation in online services, internet and amplification using data vehicles like CD-Rom, DVD-ROM etc. even in extracts require written permission by Life Science Nord e.V. Life Science NOrd e.V. is not responsible for content of external links and and foreign contents.

In case you would like to use our newsletter via email as a free-of-charge and effective PR tool, please send us your company news that we eill publish in the following issue. Profit from this communication platform, make new contacts and take care of existing ones.


Simone Hauck
PR & Communications Manager

P +49.40.471 96-423


  • Desitin

Content loading failure